Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 6 | Respiratory Research

Fig. 6

From: LncRNA SNHG16 promotes pulmonary fibrosis by targeting miR-455-3p to regulate the Notch2 pathway

Fig. 6

SNHG16 regulated expression of Notch2 by targeting miR-455-3p. a Notch2 mRNA wide-type (Notch2 WT) and the mutated-type (Notch2 MUT) in the miR-455-3p binding sites were shown. b Luciferase activity of HEK293 cells co-transfected with miR-455-3p mimics or NC mimics and luciferase reporters containing Notch2 3′-UTR WT or Notch2 3′-UTR MUT transcript were determined by dual-luciferase reporter assays. c The expression level of protein Notch2 was detected in miR-455-3p mimic, inhibitor and their control groups (control, NC-inh) by western blot. d The expression level of protein Notch2 were analyzed by western blot in TGF-β1 treated lung fibroblast cells which co-transfected with sh-SNHG16 or its control (sh-NC) and miR-455-3p inhibitor or its control (NC-inh). Data were expressed as mean ± SD. **P < 0.01 vs control; ##P < 0.01 vs NC-inh or TGF-β1 + Ad sh-NC; $$P < 0.01 vs TGF-β1 + Ad sh-SNHG16, represent statistically difference

Back to article page